WATSON 3256
Pill imprint WATSON 3256 has been identified as Cyclobenzaprine hydrochloride 5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; migraine; fibromyalgia; temporomandibular joint disorder and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy.
Cyclobenzaprine 5 mg is not subject to the Controlled Substances Act.
See also related documents.
Cyclobenzaprine hydrochloride Images
- Imprint:
-
WATSON
3256 - Strength:
- 5 mg
- Color:
- White
- Size:
- 8.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
croscarmellose sodium
dibasic calcium phosphate
hydroxypropyl cellulose
hypromellose
polyethylene glycol
magnesium stearate
microcrystalline cellulose
titanium dioxide
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Watson Pharmaceuticals
- National Drug Code (NDC):
- 00591-3256
| NDC Code | Manufacturer / Repackager |
|---|---|
| 16590-0544 | Stat RX USA LLC (repackager) |
| 21695-0036 | Rebel Distributors Corp (repackager) |
| 23490-7673 | Palmetto State Pharmaceuticals Inc (repackager) |
| 18837-0205 | Innoviant Pharmacy Inc (repackager) |
| 68071-0462 | Nucare Pharmaceuticals Inc (repackager) |
| 54868-5597 | Physicians Total Care Inc (repackager) |
| 33261-0377 | Aidarex Pharmacuticals LLC (repackager) |
| 68258-7013 | Dispensing Solutions Inc. (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Cyclobenzaprine Hydrochloride resources
- Cyclobenzaprine
- Cyclobenzaprine (Wolters Kluwer)
- Cyclobenzaprine Extended-Release Capsules (Wolters Kluwer)
- cyclobenzaprine (Cerner Multum)
- cyclobenzaprine (Micromedex) - Includes Dosage Information
- Cyclobenzaprine (AHFS DI)
- Cyclobenzaprine (FDA)
- Cyclobenzaprine Capsules (FDA)
- Cyclobenzaprine Hydrochloride (Wolters Kluwer)
Search Again
